Summary

TrovaGene, Inc. (TrovaGene), formally known as Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology can be used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company also holds worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in California, the US.

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
TrovaGene, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
TrovaGene, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
TrovaGene, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
Venture Financing 12
TrovaGene Raises US$6.6 Million In Venture Financing 12
Partnerships 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 13
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 14
TrovaGene Enters Into An Agreement With Skyline Diagnostics 15
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 16
Xenomics Signs An Agreement With SEQUENOM 17
Warnex Enters Into Licensing Agreement With Xenomics 18
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 19
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 21
Equity Offering 22
Trovagene Completes Private Placement Of Shares For US$15 Million 22
Trovagene Completes Private Placement Of Units For US$4 Million 24
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 25
TrovaGene, Inc. - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations and Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Mar 19, 2014: Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care 30
Oct 16, 2013: Trovagene announces pharmaceutical collaboration for oncogene mutation detection study 30
Jan 03, 2013: Trovagene Announces Clinical Collaboration With University of Texas MD Anderson Cancer Center To Detect Transrenal BRAF Mutations In Primary And Metastatic Cancers 31
Financial Announcements 31
Mar 17, 2014: Trovagene Reports Fourth Quarter and Full Year 2013 Financial Results 31
Nov 14, 2013: Trovagene, Inc. reports third quarter 2013 financial results 32
Nov 08, 2013: Trovagene Schedules Release of Third Quarter 2013 Financial Results and Hosts Investor Conference Call 33
Aug 14, 2013: Trovagene Announces Second Quarter 2013 Earnings 33
Apr 01, 2013: Trovagene Reports 2012 Results 34
Apr 01, 2013: Trovagene, Inc., Announces Fourth Quarter and Year End 2012 Earnings 35
Corporate Communications 36
Mar 26, 2014: Genomics and Molecular Diagnostics Pioneer Charles Cantor, Ph.D., Joins Trovagene's Scientific Advisory Board 36
Feb 19, 2014: Dr. Rodney S. Markin Joins Trovagene's Board of Directors 36
Oct 30, 2013: Dr. Paul Billings Joins Trovagene's Board of Directors 37
Mar 04, 2013: Trovagene Appoints Mark Erlander As CSO 37
Government and Public Interest 38
Dec 02, 2013: Trovagene to Present at 25th Annual Piper Jaffray Conference 38
Oct 14, 2013: Trovagene Announces Abstracts to be Presented at Molecular Targets and Cancer Therapeutics Conference 38
Sep 04, 2013: Trovagene to Present at Two Healthcare Conferences 38
Jun 27, 2013: Trovagene to Present at the OneMedForum Conference 39
Jun 03, 2013: Trovagene to Present at the Jefferies 2013 Global Healthcare Conference 39
Product News 39
Mar 27, 2013: Trovagene Launches Urine-Based HPV Test 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables

TrovaGene, Inc., Medical Equipment, Key Facts, 2013 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
TrovaGene, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
TrovaGene, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
TrovaGene, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
TrovaGene, Inc., Deals By Market, 2008 to YTD 2014 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
TrovaGene Raises US$6.6 Million In Venture Financing 12
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 13
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 14
TrovaGene Enters Into An Agreement With Skyline Diagnostics 15
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 16
Xenomics Signs An Agreement With SEQUENOM 17
Warnex Enters Into Licensing Agreement With Xenomics 18
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 19
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 21
Trovagene Completes Private Placement Of Shares For US$15 Million 22
Trovagene Completes Private Placement Of Units For US$4 Million 24
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 25
TrovaGene, Inc., Key Competitors 27
TrovaGene, Inc., Key Employees 28
TrovaGene, Inc., Other Locations 29

List of Figures

TrovaGene, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
TrovaGene, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
TrovaGene, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Jiangsu Yuwell Medical Equipment & Supply co.,Ltd (Jiangsu Yuwell) is a medical equipment company. The company manufactures and distributes medical equipment for healthcare organizations. It offers ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.